Studies & Treatments

Studies & Treatments

Ophthalmology

The Stem Cell Ophthalmology Treatment Study II  (SCOTS 2) is the largest study in the world using autologous (from the patient themselves) Bone Marrow Derived Stem Cells. We have published 5 articles in high quality, peer-reviewed medical and scientific journals and have 2 additional under review and several more planned in the next 2 years. We are interested in patients with vision loss as a consequence of optic nerve or retinal diseases.

We have treated over 47 different eye diseases, including major diseases such as glaucoma, NAION, optic atrophy, hereditary optic neuropathies, Age-Related Macular Degeneration (AMD), Diabetic Retinopathies, Stargardts, Retinitis Pigmentosa, hereditary maculopathies, and retinopathies.


We are not substituting for the standard of care- we wish patients to have completed all routine treatment that is available before consulting us.

More Information →
a close up of a person 's eye with a yellow spot in the middle .

Neurology

The Neurologic Stem Cell Treatment Study (NEST) is the largest neurologic study using autologous (from the same person) Bone Marrow-Derived Stem Cells. We are interested in the numerous neurologic diseases and degenerations that are present. The major categories include Chronic Stroke (CVA), Parkinson's Disease, MSA (Multiple System Atrophy), PSP (Progressive Supranuclear Palsy), ALS (Anterior Lateral Sclerosis), Multiple Sclerosis ( RR, PP, PR, SP), Traumatic Brain Injury (TBI), Peripheral Neuropathy (including Diabetic Neuropathy).

Still, diseases are considered on a case-by-case basis. Typically, patients receive BMSC intravenously and intranasally.

More Information →
a close up of a blue brain on a black background .

Autism Spectrum Disorder

an illustration of a brain with a tree inside of it

Bone Marrow-Derived Stem Cells in the treatment of Autism Spectrum Disorder (ASD) in patients over the age of 18. Evaluation with standard ASD testing, including the AQ test, is required for evaluation. There are a number of preclinical and clinical publications suggesting that BMSC may be of help in various neurologic diseases. One of the more recent university-based studies, Autologous Umbilical Cord Blood Infusion for Children With Autism Spectrum Disorder (ASD) has been conducted at Duke University Medical Center in North Carolina.

NEST is not substituting for standard of care- we wish patients to have completed all routine treatment that is available before considering participation in NEST.


More Information →

Alzheimer's Disease and Dementias

Eligible conditions may include Alzheimer's Disease (ALZ), Lewy Body Dementia, Multi-infarct Dementia, CADASIL Dementia, and others. Treatment in NEST is in addition to standard of care. Patients are encouraged to continue care including prescribed medications as suggested by their neurologist.

Next Steps...

For more information, visit each of the studies individually.

→ Contact Us
Share by: